Interestingly, CF is associated with a defective NRF2 expression, contributing to the excessive oxidative stress and lung tissue damage, whereas CFTR modulators rescue NRF2 function and therefore improve tissue oxidative status [96]. The gene discussed is CFTR; the disease is cystic fibrosis.